Author details

Full Name

Shan Lu

Affiliation

ORCID

Career Start Year

1987

Papers

188

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36426608	Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses.	Emerging Microbes and Infections	2023
35140230	Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV.	npj Vaccines	2022
36160273	Impact of Asymptomatic Neurosyphilis on Patients Quality of Life and Social Stigma.	Psychology Research and Behavior Management	2022
34986207	Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice.	PLoS Pathogens	2022
34919019	Future science prize goes to EMI editorial board members and the science of emerging infections.	Emerging Microbes and Infections	2022
33555988	A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques.	Emerging Microbes and Infections	2021
33853515	DNA priming immunization is more effective than recombinant protein vaccine in eliciting antigen-specific B cell responses.	Emerging Microbes and Infections	2021
33574444	Targeting the DNA replication stress phenotype of KRAS mutant cancer cells.	Scientific Reports	2021
33875266	The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59Â years: A phase I randomized, double-blinded, controlled trial.	Vaccine	2021
33980582	Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques.	Journal of Immunology	2021
32990278	Antibody responses in COVID-19 patients.	Journal of Biomedical Research	2020
31941770	Glycan Profiles of gp120 Protein Vaccines from Four Major HIV-1 Subtypes Produced from Different Host Cell Lines under Non-GMP or GMP Conditions.	J Virol	2020
32148172	Timely development of vaccines against SARS-CoV-2.	Emerging Microbes and Infections	2020
31399502	S100A16-induced adipogenesis is associated with up-regulation of 11 Î²-hydroxysteroid dehydrogenase type 1 (11Î²-HSD1).	Bioscience Reports	2019
31270317	Author Correction: The wide utility of rabbits as models of human diseases.	Experimental and Molecular Medicine	2019
31069793	S100A16, a novel lipogenesis promoting factor in livers of mice and hepatocytes in vitro.	Journal of Cellular Physiology	2019
29789565	The wide utility of rabbits as models of human diseases.	Experimental and Molecular Medicine	2018
30027758	Using DNA Immunization to Elicit Monoclonal Antibodies in Mice, Rabbits, and Humans.	Human Gene Therapy	2018
30153309	Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to Î±4Î²7.	PLoS Pathog	2018
29997214	Structural Comparison of Human Anti-HIV-1 gp120 V3 Monoclonal Antibodies of the Same Gene Usage Induced by Vaccination and Chronic Infection.	Journal of Virology	2018
30230936	DNA Vaccination in 2018: An Update.	Human Gene Therapy	2018
30129778	One Group's Historical Reflections on DNA Vaccine Development.	Human Gene Therapy	2018
29449582	Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.	Emerging Microbes and Infections	2018
29118121	HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.	J Virol	2018
29498807	Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.	Cytometry. Part A : the journal of the International Society for Analytical Cytology	2018
28102671	Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting.	Biochemistry	2017
28933684	Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.	Human Vaccines and Immunotherapeutics	2017
29049006	The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS.	Human Vaccines and Immunotherapeutics	2017
28827346	Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope.	Proc Natl Acad Sci U S A	2017
28185743	Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.	Vaccine	2017
27630232	Fc Receptor-Mediated Activities of Env-Specific Human Monoclonal Antibodies Generated from Volunteers Receiving the DNA Prime-Protein Boost HIV Vaccine DP6-001.	Journal of Virology	2016
26887860	Follicular regulatory TÂ cells repress cytokine production by follicular helper TÂ cells and optimize IgG responses in mice.	European Journal of Immunology	2016
27048742	DNA immunization as a technology platform for monoclonal antibody induction.	Emerging Microbes and Infections	2016
26555265	Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.	Journal of Biological Chemistry	2016
26590319	A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.	Journal of Immunology	2016
27707920	Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.	Journal of Virology	2016
27630234	Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.	Journal of Virology	2016
26062906	N-Linked Glycosylation at an Appropriate Position in the Pre-S2 Domain Is Critical for Cellular and Humoral Immunity against Middle HBV Surface Antigen.	Tohoku Journal of Experimental Medicine	2015
25488991	Identification of Aim2 as a sensor for DNA vaccines.	Journal of Immunology	2015
26379400	Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients.		2015
26251831	Structural analysis of a novel rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120 C4 region critical for receptor and co-receptor binding.	Emerging Microbes and Infections	2015
25139902	Genome-wide mutant fitness profiling identifies nutritional requirements for optimal growth of Yersinia pestis in deep tissue.	mBio	2014
25290657	Novel vaccine technology and the future of vaccine science.	Human Vaccines and Immunotherapeutics	2014
25424808	The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination.	Human Vaccines and Immunotherapeutics	2014
25424804	Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.	Human Vaccines and Immunotherapeutics	2014
26344472	DNA Immunization for HIV Vaccine Development.	Vaccines	2014
26038519	EV71 vaccines: a milestone in the history of global vaccine development.	Emerging Microbes and Infections	2014
26038502	Using convalescent whole blood or plasma as passive immune therapy for the global war against Ebola.	Emerging Microbes and Infections	2014
24397904	Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice.	Vaccine	2014
24335308	A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication.	J Virol	2014